期刊文献+

伊贝沙坦治疗充血性心力衰竭疗效观察 被引量:6

A study on the efficacy of irbesartan in the treatment of congestive heart failure
原文传递
导出
摘要 目的 探讨伊贝沙坦治疗慢性充血性心力衰竭 (CHF)的临床疗效。方法  36例CHF患者给予伊贝沙坦 15 0mg/d ,治疗 8周 ,观察治疗前后患者的临床症状、超声心动图指标、心功能、6min步行距离及不良反应。结果 治疗后临床症状、超声心动图指标、心功能、6min步行距离明显改善 (P <0 0 1和P <0 0 5 ) ,总有效率达 88 89%。结论 伊贝沙坦治疗CHF疗效显著 。 Objective To evaluate the clinical efficacy of irbesartan in treating patients with congestive heart failure.Methods 36 patients were given irbesartan 150mg orally once a day for 8 weeks.The changes of clinical symptom,echocardiogram index,cardiac function (NYHA).6min Walk trail and adverse reactions of the patients were observed.Results After therap,clinical symptom,echocardiogram index,cardiac function.6min walk trail were markedly improved(P<0.01和P<0.05),irbesartan had few adverse effects and patients tolerance was perfect.The rate of efficiency was 88.89%.Conclusion The effect of irbesartan in treating patients with congestive heart failure is satisfactory and it is safe in the treatment of congestive heart failure.
机构地区 宿州市立医院
出处 《中国基层医药》 CAS 2004年第9期1063-1064,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 治疗 伊贝沙坦 CHF 步行 充血性心力衰竭 患者 心功能 Irbesartan Heart failure AngiotensinⅡ
  • 相关文献

参考文献2

二级参考文献13

  • 1Kang PM, Landau AJ, Eberhardt RT, et al. Angiotensin Ⅱ receptor antagonists:a new approach to blockade of the reninangiotensin system. Am Heart J, 1994; 127(5) : 1388-1401.
  • 2Pitt B,pool-wilson PA. Segal R,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randornised trial-the losartan heart failure survival study ELITE Ⅱ. Lancet, 2000 ;355(9215) : 1582- 1587.
  • 3Hamroff G,Blaufarb I,Mancini D,et al.Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treat with angiotensin-converting enzyme inhibitors for heart failure[].Journal of Cardiovascular Pharmacology.1997
  • 4Krombach RS,Clair MJ,Hendrick JW,et al.Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns[].Cardiovascular Research.1998
  • 5Baruch L,Anand I,Cohen IS,et al.Augmented short-and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patient with heart failure[].Circulation.1999
  • 6Lang RM,Elkayam U,Yellen LG,et al.Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure[].Journal of the American College of Cardiology.1997
  • 7McKelvie RA,Yusuf S,Pericak D,et al.Comparison of candesartan,enalapril, and their combination in congestive heart failure[].Circulation.1999
  • 8Hamroff G,Blaufarb I,Mancini D,et al.Maximally recommended doses of ACE inhibitors do not completely prevent ACE-mediated formation of Ang II in CHF[].Circulation.2000
  • 9Dickstein K,Chang P,Willenheimer R,et al.Comparison of the effects of Losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure[].Journal of the American College of Cardiology.1995
  • 10Crozier I,Ikram H,Awan N,et al.Losartan in heart failure:hemodynamic effects and tolerability[].Circulation.1995

共引文献53

同被引文献23

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部